The current evidence base points to several overlapping molecular pathways operating in parallel: VEGFR2/Akt/eNOS Angiogenic Signalling A primary mechanistic axis involves upregulation of vascular endothelial growth factor receptor 2 (VEGFR2), leading to activation of the Akt/eNOS (endothelial nitric oxide synthase) downstream pathway
Whether the research focus is metabolic, body composition, or exploratory, the core principles remain: Start low: 0.5 to 1 mg is a safe starting dose
The average diet supplies about 5 to 15 mcg/day of Vitamin B12 in a protein-bound form that is available for absorption after normal digestion
F.MerwinJ
This means that AOD-9604: Does not raise IGF-1 , no systemic anabolic effect Does not cause insulin resistance , a frequent side effect of high doses of hGH Has no growth effect , no influence on the growth of bones, soft tissues, organs Does not cause acromegaly , because it does not act as GH It is one of the few molecules where we have managed to surgically separate one effect of GH (lipolysis) from the others
